[go: up one dir, main page]

UA97496C2 - Композиция укорененных мицеллярных наночастичек и способ ее получения - Google Patents

Композиция укорененных мицеллярных наночастичек и способ ее получения

Info

Publication number
UA97496C2
UA97496C2 UAA200904939A UAA200904939A UA97496C2 UA 97496 C2 UA97496 C2 UA 97496C2 UA A200904939 A UAA200904939 A UA A200904939A UA A200904939 A UAA200904939 A UA A200904939A UA 97496 C2 UA97496 C2 UA 97496C2
Authority
UA
Ukraine
Prior art keywords
preparing
embedded
micelles
composition
micellar nanoparticles
Prior art date
Application number
UAA200904939A
Other languages
English (en)
Ukrainian (uk)
Inventor
Жан П. Мешвитцер
Original Assignee
Еббот Хелскеа Продактс Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Еббот Хелскеа Продактс Б.В. filed Critical Еббот Хелскеа Продактс Б.В.
Priority claimed from PCT/EP2007/061194 external-priority patent/WO2008046905A1/en
Publication of UA97496C2 publication Critical patent/UA97496C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение касается термостабильной твердой композиции на основе мицелл с размером в нанодиапазоне, которые содержат труднорастворимое химическое соединение, растворенное во вспомогательном материале, а мицеллы укоренены в водорастворимом носителе. Изобретение также касается способа получения термостабильной твердой композиции и способа приготовления фармацевтических дозировочных форм, которые содержат такую композицию.
UAA200904939A 2006-10-20 2007-10-19 Композиция укорененных мицеллярных наночастичек и способ ее получения UA97496C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06122648 2006-10-20
PCT/EP2007/061194 WO2008046905A1 (en) 2006-10-20 2007-10-19 Micellar nanoparticles of chemical substances

Publications (1)

Publication Number Publication Date
UA97496C2 true UA97496C2 (ru) 2012-02-27

Family

ID=37671256

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200904939A UA97496C2 (ru) 2006-10-20 2007-10-19 Композиция укорененных мицеллярных наночастичек и способ ее получения

Country Status (8)

Country Link
CN (2) CN101686946A (ru)
AR (1) AR063330A1 (ru)
BR (1) BRPI0719826A8 (ru)
HK (1) HK1199829A1 (ru)
MX (1) MX2009004124A (ru)
SA (1) SA07280548B1 (ru)
TW (1) TWI392507B (ru)
UA (1) UA97496C2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI661841B (zh) * 2017-04-19 2019-06-11 三凡生技研發股份有限公司 用於分散疏水性植物萃取物之載劑
EP3424493A1 (en) * 2017-07-07 2019-01-09 SolMic Research GmbH Stable cannabinoid compositions
CN110302155B (zh) 2019-07-31 2021-09-21 江南大学 一种黄原胶共聚物纳米胶束的制备方法及其应用
CN112915121A (zh) * 2019-12-06 2021-06-08 汉义生物科技（北京）有限公司 一种大麻素纳米胶束制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700866B2 (en) * 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
EP1415648B1 (en) * 2001-07-13 2006-11-22 NanoCarrier Co., Ltd. Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof
IL153277A0 (en) * 2002-12-04 2003-07-06 Pharmos Corp High enantiomeric purity dexanabinol for pharmaceutical compositions
US20060003976A1 (en) * 2004-06-04 2006-01-05 Yuehua Zhang Cholesterol/bile acid/bile acid derivative-modified therapeutic drug compounds

Also Published As

Publication number Publication date
MX2009004124A (es) 2009-07-22
AR063330A1 (es) 2009-01-21
BRPI0719826A2 (pt) 2014-05-06
TWI392507B (zh) 2013-04-11
BRPI0719826A8 (pt) 2017-04-04
HK1199829A1 (en) 2015-07-24
SA07280548B1 (ar) 2011-10-08
CN104188926A (zh) 2014-12-10
TW200824711A (en) 2008-06-16
CN101686946A (zh) 2010-03-31

Similar Documents

Publication Publication Date Title
EA200900572A1 (ru) Мицеллярные наночастицы с химическими субстанциями
MX2010011564A (es) Formulaciones mejoradas para ingredientes farmaceuticos activos de permeabilidad deficiente.
MX2009005727A (es) Nanoparticulas de entidad anfifilica.
WO2009135190A3 (en) Therapeutic calcium phosphate particles and methods of making and using same
ZA200803350B (en) Method of acting upon organism by targeted delivery of biologically active substances into mitochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
WO2004052336A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
EA200870219A1 (ru) Стабилизированные сукцинатом витамина е фармацевтические композиции, способы их получения и применения
MY161620A (en) Oral care formulations that enhance amount of soluble zinc
ATE424848T1 (de) Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen
MXPA05003591A (es) Materiales basados en ciclodextrina, composiciones y usos relacionados a los mismos.
WO2008089151A3 (en) High dose film compositions and methods of preparation
WO2011067791A3 (en) Process for preparing pharmaceutical ophthalmic compositions
GB2452461A (en) Aqueous compositions containing a hydrophobic material
WO2008017867A3 (en) Antiretroviral solid oral composition with at least one water insoluble polymer
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
TW201129392A (en) Dissolvable films containing high concentrations of nonionic surfactants such as polysorbates to enhance high solid loadings
UA90708C2 (ru) Таблетки с улучшенной дисперсностью лекарственного вещества
UA86441C2 (ru) (2-гидроксиэтил)триметиламмония тиоктат (холина тиоктат), имеющий гепатопротекторное, гипоаммониемическое и детоксицирующее действие, способ его получения, фармацевтическая композиция на его основе
UA97496C2 (ru) Композиция укорененных мицеллярных наночастичек и способ ее получения
WO2010149309A3 (de) Cycloalkylamidbenzoxa(thia)zole als fungizide
WO2008079963A3 (en) Pharmaceutical compositions comprising ionic complexes of active pharmaceutical ingredients
WO2010079052A3 (en) Nanoparticle compositions
MXPA05010254A (es) Composicion farmaceutica que contiene complejo de platino como sustancia activa y metodo de fabricacion de la misma.
WO2008001294A3 (en) High dose oral pharmaceutical compositions of artemether and lumefantrine
WO2009148955A3 (en) Multi-arm amines and uses thereof